Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIVOSIRAN vs GLATIRAMER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GIVOSIRAN vs GLATIRAMER: Safety Overview

Metric GIVOSIRAN GLATIRAMER
Total FAERS Reports 1,224 46,357
Deaths Reported 32 696
Death Rate 2.6% 1.5%
Hospitalizations 595 5,831
Average Patient Age 45.1 yrs 48.4 yrs
% Female Patients 89.5% 81.0%
FDA Approval Date Nov 20, 2019 Apr 16, 2015
Manufacturer Alnylam Pharmaceuticals, Inc. Zydus Pharmaceuticals USA Inc.
Route SUBCUTANEOUS SUBCUTANEOUS
Marketing Status Prescription Discontinued